title: Multidrug therapy in paucibacillary leprosy--a five year experience.
abstract: 736 paucibacillary (PB) patients were given multidrug therapy (MDT) for at least 6 months. Overall, 44% became inactive after 6 doses, and 69% after 12 doses. However, 27% remained active at the time of analysis. It is recommended that at least 12 doses of MDT be given to PB patients irrespective of the type.
authors.affiliation: Lok Seva Sangam, D-1, Everard Nagar, Bombay.
authors.forename: A
authors.initials: A
authors.lastname: Grugni
authors.forename: N J
authors.initials: NJ
authors.lastname: Nadkarni
authors.forename: M S
authors.initials: MS
authors.lastname: Kini
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D011446:Prospective Studies; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D003622:Dapsone; D012293:Rifampin